QuidelOrtho Corp (QDEL): Total Assets
$5.77B
As of 2025-12-28
$5.72B
As of 2026-06-28
-13.3%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $5.77B | -10.2% | 2026-02-19, Balance as of period end |
| 2024-12-29 | $6.42B | -25.0% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $8.56B | -3.3% | 2025-02-27, Balance as of period end |
| 2023-01-01, Fiscal 2022 | $8.86B | +264.4% | 2024-08-01, Balance as of period end |
| 2022-01-02, Fiscal 2021 | $2.43B | n/a | 2023-02-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $5.77B | -10.2% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $3.35B | +1.7% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $2.23B | +12.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $3.35B | -2.8% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $706.60M | -31.2% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $842.13M | -29.3% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.46M | -0.6% |
Compare QDEL, IDXX, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗